Resources

Category: Blog Posts

Pharma leaders express excitement and confidence in their structured content authoring platform, using governed, reusable content to maintain authority and traceability across lifecycle change.

3 signs you need a partner, not just a platform

In Pharma, one form of technology that offers great promise is a structured component authoring (SCA) platform. When Life Sciences organizations choose to roll out new tools of any type, hopes are typically high; adoption needs to go smoothly all the way from implementation to individual use. You want resources to support functionality. And you want a solution that saves your organization time and money on whatever problem you thought the product might solve.

Pharma leaders discuss evolving regulatory requirements, sharing perspectives on how governed, traceable content can support consistent responses to change across global markets.

DIA Europe Takeaways: AI, Componentization, and Standards

Recently, Docuvera attended DIA Europe 2023, a conference organized by the Drug Information Association (DIA), a global nonprofit. The event aims to bring together Life Sciences professionals to exchange knowledge and collaborate to improve healthcare worldwide and provides a platform to discuss the latest developments in healthcare and regulatory science.

Pharma leaders express confidence in their new structured content authoring platform, using governed, reusable content to maintain authority and traceability through review, approval, and lifecycle change.

Can your documentation solution flex with your organization?

For Pharma businesses of all sizes, the right tools can enable efficiency, collaboration and effective use of available resources. When it comes to medical information writing teams, structured component authoring (SCA) is a solution with great promise for a complex authoring process. However, not all SCA platforms are designed to flex to match the needs of all organizations.

Webinar announcement on medical affairs

Behind the scenes: Why medical information authors need SCA

We believe that Life Sciences organizations need a centralized platform for medical information authoring, so we’re sitting down with experts to examine some of the greatest inefficiencies in the industry. To kick off our series, we interviewed Docuvera Medical Affairs SME Kenneth Galloway to hear what challenges writers face and learn how structured component authoring (SCA) can streamline the process for the whole organization.

Pharma leader reviews an online document approval process, verifying authorization, review history, and traceability as regulated content moves through lifecycle change.

Join the journey to digital enablement

To keep up with the times or rather, persevere to the future, Life Sciences organizations need to match the pace of progress. Ironically, this industry has been one of the slowest to adopt technology to help optimize the processes and workflows that could essentially change the world.

Illustration of connected octagons represents relationships between governed structured content components, preserving authority, metadata, and traceability as regulated information is reused across the lifecycle.

7 necessities for structured component authoring, part 2

For Life Sciences organizations, the medical authoring process requires agility to comply with complex documentation requirements. From dozens of authors and strict regulations to multiple review cycles, you need a solution that moves with your projects — a flexibility that might be missing if you still depend on programs like Microsoft Word for your content development and publication.

Illustration of connected lines represents relationships between governed structured content components, preserving authority, metadata, and traceability as regulated information is reused across the lifecycle.

7 necessities for structured component authoring, part 1

For Life Sciences organizations, agility in the face of regulatory change is essential. In the complex medical authoring process, content development and publishing should be easy and intuitive, and not get in the way of your groundbreaking work.

Life sciences leader reviews regulated documents on a monitor, verifying authoritative content, approval history, and traceability to support lifecycle change and regulatory responses.

Do it write: from implementation to authoring in no time

When organizations invest in new platforms and technology, it’s a big deal. From making the actual purchase of the tool to using IT resources to getting everything up and running, it can be a major lift — and a major expense.

Pharma team reviews regulated documents together, verifying authoritative content, approval history, and traceability as information moves through review and lifecycle change.

3 tips to efficiently manage the internal and external medical writing process

For authors in the Life Sciences industry, there are typically many moving parts — and many people working simultaneously — on any given project. Getting people on the same page is critical when you are creating medical documentation. And, this is even more of a challenge when you have a combination of internal and external teams collaborating on a project.

Legacy copy-and-paste process shows regulated content duplicated across documents, making it difficult to preserve authoritative statements, traceability, and control as content changes across the lifecycle.

SCA: Authoring that feels familiar (but better)

Medical authoring has long relied on programs like Microsoft Word, and with good reason. The desktop publishing platform is user-friendly, universally familiar and has hardly changed in the three decades since its first release.

Pharma leader frustrated with an outdated content system that makes it difficult to identify authoritative, traceable regulated information and respond confidently to lifecycle change.

5 signs your life sciences org needs structured content

Are you still using a program like Microsoft Word for your medical authoring and documentation? What if we told you that AI and structured content  can give authors advantages like flexibility, improved compliance capabilities, better data integration and more?

Pharma team celebrates a successful shift from document-centric processes to governed structured content, gaining confidence in authoritative, traceable information across lifecycle change.

Implementation through innovation: fully-supported SCA

When making a decision on a technology vendor, there are many considerations. Will it alleviate a significant problem? What does the onboarding process look like? Is there a support system for after the installation?

Global pharma team review an outdated document-based system, searching for authoritative, traceable information needed to answer regulatory questions and manage lifecycle change with confidence.

SCA: A solution that works from author through IT

IT teams are the unsung heroes of every enterprise organization. From securing endpoints, maintaining the network and troubleshooting, to executing new technologies that can change the course of business, IT is busy. And, like many departments, IT is often under-resourced and overworked. The last thing they want is to undertake launching a solution that requires extensive support or barriers to implementation.

Global pharma leaders reviewing their options

Keys to SCA implementation success

Technology can be a game-changer that streamlines complex processes, enhances productivity and increases efficiency. For Life Sciences organizations, a structured component authoring (SCA) platform can help transform the medical authoring and documentation process — as long as you can get everyone on board. With this in mind, we’re sharing our top three tips for a successful SCA implementation.

Global pharma leaders review an outdated document-based system, searching for authoritative, traceable information needed to answer regulatory questions and manage lifecycle change with confidence.

Why SCA has been a great idea that never achieved its promise, until now.

On the surface, structured component authoring (SCA) is a concept that makes sense in theory but has been hard to implement for many organizations. Much of the medical authoring and documentation done today is accomplished through standard desktop publishing programs like Microsoft Word — but these programs are not designed with Life Sciences authors in mind.

Hand holding cloud-based data represents governed structured content that preserves authority, metadata, and traceability as regulated information moves securely across systems and lifecycle change.

Power what’s possible with structured component authoring

Imagine this: you’re working on groundbreaking innovations for the Life Sciences industry. Your team is composed of multiple people with various specialties, spread across time zones (and sometimes, continents). There are clinical trials, endless regulatory and ethics requirements, and countless changes to critical documentation  in the authoring process. You might be on the cusp of changing the world — yet you’re using Microsoft Word to manage and publish your information.

See what structured component authoring can do for you.

Scroll to Top